Скачать или смотреть Can GCCs Help Reimagine Pharma R&D Processes and Operations?

Pharma R&D continues to take longer, cost more, and attract greater scrutiny from regulators than ever before. To address these challenges, R&D leaders are turning to technology to drive greater effectiveness and efficiencies. On this journey, can GCCs help global pharma chart a new course in modernizing and transforming R&D processes, and become future-ready?

At the inaugural Future-Ready Pharma GCC Summit, industry leaders Nataraj Kalyanaraman from Bristol Myers Squibb, Vivek Jha from Novartis, Dr. Nandita Adhikary from Sanofi and Dinesh Shenoy from Eugia Pharma came together for an insightful panel discussion. Hosted by T-Hub, in partnership with Indegene, the summit saw these leaders exchange thoughts on how GCCs can help modernize pharma R&D processes and embrace new technologies with much greater vigor, driving better patient outcomes more cost-effectively.

Watch the video for more!
#FutureReadyHealthcare